S1706

A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer
Contact phone
Clinical Trials Office – 517.364.9400
Principal investigator
Gordan Srkalovic
Trial Category
Cancer
Trial SubCategory
Breast